Antagonistic effect of dauricine of experimental arrhythmias.
D000470:Alkaloids / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D044182:Benzylisoquinolines; D002415:Cats; D005260:Female; D006168:Guinea Pigs; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D011817:Rabbits; D051381:Rats; D044005:Tetrahydroisoquinolines; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D044182:Benzylisoquinolines; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; C009438:tetrandrine; C035934:dauricine